2025 Royalty Rate Survey Results & Best Practices for Deal Negotiation
hosted by the New York/New Jersey Chapter

Scott Weingust, Managing Director, Stout

Scott Weingust is the leader of Stout’s Intellectual Property Valuation practice. Mr. Weingust has more than 28 years of experience providing consulting services to corporations, law firms, universities, and investment firms primarily in the areas of intellectual property (IP) valuation, damages, monetization, and management.   His practice focuses on valuing patents, trademarks, copyrights, trade secrets, the right of publicity (i.e., name, image, and likeness), software, license agreements, domain names, and other intangible assets.  Scott has valued IP and other intangible assets for a variety of purposes including: transactions (licensing, purchase/sale, joint ventures, mergers and acquisitions), tax strategy and compliance (related-party transactions, trust & estate issues), corporate strategic decision-making, use of intellectual property for capital raising efforts (debt and equity), financial reporting, litigation, regulatory compliance (Stark Law, Anti-Kickback Statute), and bankruptcy, among others. He has been directly involved in IP licensing negotiations and has developed many dynamic IP pricing/valuation models to inform transactions and investment decisions.  Scott is currently an adjunct professor at DePaul University’s College of Law where he teaches a course on IP valuation. He has also previously taught classes on IP valuation and related topics at the New York University School of Law, The John Marshall Law School, Michigan State University’s College of Law, and the Illinois Institute of Technology’s Chicago-Kent College of Law.  Scott has spoken at conferences and other events for many organizations including the Intellectual Property Owners Association (IPO), Licensing Executives Society (LES), American Bar Association (ABA), American Intellectual Property Law Association (AIPLA), and the Intellectual Property Law Association of Chicago (IPLAC), among others.

Lina Lahoz, Director, Strategy & Portfolio, Teva Pharmaceuticals

Lina Lahoz is Director of Strategy & Portfolio at Teva Pharmaceuticals and former Chair of the Licensing Executives Society (LES) New Jersey chapter. With over 20 years of experience in the pharmaceutical industry, she has led cross-functional teams in structuring and negotiating complex global development and licensing agreements.

At Teva, Lina plays a pivotal role in product selection and pipeline licensing, aligning technical feasibility with commercial strategy to maximize long-term value. She brings a practical, deal-making perspective to royalty terms, having evaluated and executed a wide range of transactions across multiple therapeutic areas and development stages.

Her experience spans due diligence, term sheet analysis, and partner engagement, and she has represented Teva at BioNJ’s BioPartnering Conference, fostering connections with innovative biotech companies.

Lina holds an MBA in Finance & Investments from Baruch College and a bachelor’s degree in Industrial Engineering from Xavier University.